Publications by authors named "T M Laufer"

In systemic lupus erythematosus (lupus), environmental effects acting within a permissive genetic background lead to autoimmune dysregulation. Dysfunction of CD4+ T cells contributes to pathology by providing help to autoreactive B and T cells, and CD4+ T cell dysfunction coincides with altered DNA methylation and histone modifications of select gene loci. However, chromatin accessibility states of distinct T cell subsets and mechanisms driving heterogeneous chromatin states across patients remain poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Local treatment options for recurrence of pancreatic adenocarcinoma are limited, with median survival times of 9-13 months, but MRI-guided stereotactic body radiation therapy (MRgSBRT) may improve outcomes by allowing higher radiation doses while protecting normal tissue.
  • In a study involving 15 patients treated with MRgSBRT, the median overall survival after recurrence was 14.1 months, with local control rates of 92.3% and 83.9% at 6 and 12 months, respectively.
  • The treatment showed manageable side effects, with 47% experiencing mild acute gastrointestinal toxicity and 31% facing chronic gastrointestinal issues, but no severe
View Article and Find Full Text PDF

Foxp3 regulatory T cells (Tregs) are essential for intestinal homeostasis. Tregs in the small intestine include Helios thymus-derived Tregs (tTregs) and RORγt Tregs that differentiate in the periphery after antigenic stimulation (pTregs). TCR and costimulatory signals sustain Tregs with effector phenotypes, including those in the intestine, but it is unknown if tTregs and pTregs have similar requirements for these pathways.

View Article and Find Full Text PDF

Cancer immunotherapy often depends on recognition of peptide epitopes by cytotoxic T lymphocytes (CTLs). The tumor microenvironment (TME) is enriched for peroxynitrite (PNT), a potent oxidant produced by infiltrating myeloid cells and some tumor cells. We demonstrate that PNT alters the profile of MHC class I bound peptides presented on tumor cells.

View Article and Find Full Text PDF